01 · The Question
How Can Consent Be Informed About Research That Does Not Yet Exist?
There is an apparent paradox in long-term research repositories. Researchers want participants to make an informed decision now about studies that may happen years or decades later, perhaps using methods that do not yet exist.
If nobody can describe those future studies precisely, what exactly is the participant consenting to? The answer requires separating informed consent from perfect foresight. Consent can accommodate uncertainty, but only if the uncertainty itself is handled honestly and meaningful limits remain around what the participant authorizes.
03 · What You Need to Know
Consent Can Address Uncertainty Without Pretending to Predict the Future
Informed consent has never required perfect knowledge of the future
Even ordinary study-specific consent involves uncertainty. Researchers may not know whether an intervention will benefit a participant, whether an uncommon adverse event will occur, or exactly what the final results will show. Informed consent does not require omniscience.
Future-use consent involves a more substantial kind of uncertainty because the research activity itself may not yet be specified. The participant is therefore not consenting to the details of an unknown protocol. The participant is authorizing a range of possible future uses under stated conditions.
The object of consent changes
This distinction is central. When participants consent to a specific experiment, the object of their decision is that experiment. When they authorize future secondary research, the object of consent is broader: storage, future access, categories of use, sharing arrangements, governance conditions, and the uncertainty associated with studies that may later occur.
Consent to a known future study
The participant can evaluate the study's particular purpose, procedures, foreseeable risks, and other disclosed features.
Consent to a range of future research
The participant cannot evaluate every future protocol individually but can decide whether to authorize future uses within understandable boundaries and governance arrangements.
The Common Rule explicitly recognizes this kind of uncertainty
The U.S. Common Rule's broad-consent provisions provide a concrete example. Participants can authorize storage, maintenance, and secondary research use of identifiable private information or identifiable biospecimens even though future studies have not been individually specified.
The regulation does not solve uncertainty by pretending future purposes are known. Instead, broad consent must generally describe the types of research that may occur with enough information that a reasonable person would expect the authorization to permit those types of research. Participants may also be told that they will not receive details of specific future studies and that some of those studies might be ones to which they would not have consented individually.
That disclosure is ethically revealing: meaningful authorization of a range of future research does not imply that the participant would personally endorse every individual study inside that range.
There is a limit to what participants can actually know at the initial consent encounter
Future researchers may develop technologies that permit substantially richer inferences from existing information or specimens. Datasets that currently seem difficult to connect may later become linkable. New social conditions may make previously ordinary variables sensitive. Analytical techniques may reveal characteristics that neither participant nor original investigator anticipated.
A consent process should not disguise these epistemic limits with language suggesting that every future risk has been described. Where relevant, participants should understand that some future uses and implications cannot presently be specified.
More disclosure does not eliminate fundamental uncertainty
It is tempting to solve the problem by making the consent form longer. That has limits. Twenty paragraphs of hypothetical future scenarios still cannot describe an innovation nobody has conceived.
The more useful goal is decision-relevant disclosure: what information would reasonably help someone decide whether they are comfortable allowing future research under the proposed model? That may include the categories of research anticipated, what information or biospecimens will be retained, who may receive access, whether commercial entities may be involved where relevant, how long materials may be retained, what privacy protections apply, whether individual results will be returned, and what withdrawal can realistically accomplish.
Under the Common Rule, broad consent contains several such required disclosures, while OHRP emphasizes that participants must receive information a reasonable person would want in order to make an informed decision.
Consent to uncertainty should still be a genuine choice
A participant may reasonably decide, “I am comfortable contributing my data to future cancer research even though I cannot know the individual studies.” Another participant may reasonably decline because the uncertainty itself is unacceptable.
Respect for autonomy does not require everyone to make the same decision. It requires that the choice be meaningful, voluntary, and based on an intelligible account of what is known and unknown.
This is one reason broad consent needs meaningful boundaries rather than language designed simply to maximize institutional freedom.
Governance carries ethical weight precisely because the participant cannot review future protocols
If participants will not be recontacted for every future study, later decisions necessarily move to researchers, ethics committees, repository managers, access committees, or other governance structures. The quality of those structures therefore affects the ethical credibility of the original invitation.
Governance can assess whether a future project fits the original authorization, whether access is appropriate, whether privacy and confidentiality protections remain adequate, and whether scientific or technological developments create concerns that the original arrangements did not adequately address.
The Common Rule illustrates this division of responsibility. Its secondary-research exemption based on broad consent requires limited IRB review, including a determination that the proposed research is within the scope of the broad consent and that privacy and confidentiality protections are adequate where appropriate.
Future-use consent does not guarantee that every future study may proceed
A participant's prospective authorization can establish permission within a range. It does not obligate a repository or ethics committee to approve every project within that range. A future study may still be scientifically inadequate, excessively risky, inconsistent with privacy requirements, outside repository policy, or otherwise ethically unacceptable.
Consent is therefore a necessary consideration in many settings, but it is not the sole ethical filter.
New capabilities can push a proposed use beyond what was reasonably authorized
Imagine participants consented years ago to future research using stored information under a specified governance arrangement. A new technology later permits researchers to infer highly sensitive characteristics that could not reasonably have been anticipated at the time.
There is no universal rule that every technological development automatically invalidates prior consent. Nor should researchers assume that an old authorization automatically stretches to cover every new capability. The relevant review process should examine whether the proposed use remains within the scope of the purpose participants originally authorized , whether risks or expectations have materially changed, and whether new consent or another appropriate pathway is needed.
Consent is not the only lawful basis that may matter in data research
Another source of confusion is treating research consent and data-protection consent as interchangeable. Depending on jurisdiction, processing for research may sometimes rely on legal grounds other than consent.
Philippine National Privacy Commission guidance, for example, recognizes circumstances in which research processing does not require consent while emphasizing that personal-data processing must still have an appropriate basis and safeguards. It also rejects the notion that publicly available information constitutes blanket consent for arbitrary reuse.
Researchers therefore need to identify which kind of authorization or lawful basis they are discussing rather than assuming that one consent concept answers every ethics and privacy question.
Watch Out
Do not promise participants that future research will contain no presently unknown risks. A more defensible consent process explains the relevant uncertainty and the safeguards used to govern future decisions rather than claiming to foresee what cannot yet be known.
07 · A Quick Checklist
Before Asking Participants to Authorize Unknown Future Research
Make sure participants can understand:
What data, records, or biospecimens will be retained for possible future use.
Which categories or boundaries of future research they are being asked to authorize.
Which important details of future studies are presently unknown.
Whether materials may be shared and what types of researchers or institutions may obtain access where relevant.
How privacy, confidentiality, access, and security will be governed.
Whether they will receive information about individual future studies or research results.
What withdrawal can and cannot accomplish after data or specimens have been used or shared.
Who will decide whether a proposed future study falls within the authorization.
11 · Cite this Guide
How to Cite This Guide
This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.
Recommended (Field Guide)
APA
MLA
Chicago
Copy Citation